Skip to content

A Clinical Trial To Study The Effect Of Lashuna Rasayana And Vruddhadaru Rasayana In Patients With Inter Vertebral Disc Prolapse.

A Randomised Comparative Clinical Study To Evaluate The Effect Of Lashuna [Allium sativum linn.] And Vruddhadaru [Argyreia speciosa sweet.] Rasayana In Gridhrasi W.S.R. To Inter Vertebral Disc Prolapse. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074725
Enrollment
30
Registered
2024-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic measures. Patients between the age groups of 18-70 years. Patients with radiological evidence of Inter vertebral disc prolapse in MRI. Subjects who are willing to sign the informed consent form to participate in the research.

Exclusion criteria

Exclusion criteria: Patients with radiological evidence of fracture of vertebrae, congenital deformities, neoplastic conditions of the spine, infections of the spine, cervical inter vertebral disc prolapse, spondylolisthesis and ankylosing spondylitis. Any other systemic diseases which will interfere the treatment. People who are contraindicated for intake of Lashuna. Pregnancy and lactating mother. Had participated in any clinical trial within 3 months of screening.

Design outcomes

Primary

MeasureTime frame
Changed in the signs and symptoms of Gridhrasi. Changes in Sugar baker & Barofsky Clinical Mobility Scale and Oswestry Disability assessment questionnaire score. Objective SLR Test Neurological deficit Timepoint: 0 day 17 days 45 days

Secondary

MeasureTime frame
Objective SLR Test Neurological deficit assessed ny Herron and Turners rating.Timepoint: 0 day 17 days 45 days

Countries

India

Contacts

Public ContactDr Shrilatha Kamath T

Shri Dharmasthala Manjunatheshwara College Of Ayurveda, Hospital And Research Centre, Kuthpady,Udupi

shri9503@gmail.com9964899638

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026